Renal Cell Carcinoma News and Research

RSS
Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products.
New discovery could lead to development of new cancer treatments

New discovery could lead to development of new cancer treatments

Breast cancer patient finds new hope with potentially revolutionary treatment

Breast cancer patient finds new hope with potentially revolutionary treatment

GW researchers awarded $2.2 million NCI grant to study role of HERVs in cancer

GW researchers awarded $2.2 million NCI grant to study role of HERVs in cancer

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Experimental drug outperforms standard first-line therapy for advanced kidney cancer patients

Experimental drug outperforms standard first-line therapy for advanced kidney cancer patients

Researchers find new path to stop metastatic growth of cancer

Researchers find new path to stop metastatic growth of cancer

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer

Researchers to explore potential roles of tumor-suppressor gene in kidney cancer

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

Watch-and-wait approach may prove successful in subset of adults with advanced kidney cancer

Watch-and-wait approach may prove successful in subset of adults with advanced kidney cancer

Researchers identify potential biomarkers predictive of TKIs response in metastatic renal cancer

Researchers identify potential biomarkers predictive of TKIs response in metastatic renal cancer

Immunotherapy-treated cancer patients may develop rheumatic disorders

Immunotherapy-treated cancer patients may develop rheumatic disorders

Cytoreductive nephrectomy can extend survival of metastatic kidney cancer patients

Cytoreductive nephrectomy can extend survival of metastatic kidney cancer patients

Cabozantinib extends advanced RCC overall survival

Cabozantinib extends advanced RCC overall survival

Nivolumab drug benefits metastatic RCC patients who continued treatment beyond progression

Nivolumab drug benefits metastatic RCC patients who continued treatment beyond progression

Nivolumab and ipilimumab combination could lead to effective treatment options for SCLC patients

Nivolumab and ipilimumab combination could lead to effective treatment options for SCLC patients

Ongoing treatment with nivolumab shows benefit in advanced kidney cancer patients

Ongoing treatment with nivolumab shows benefit in advanced kidney cancer patients

Study assesses utility of tumor cfDNA as predictor of therapeutic response to immunotherapy

Study assesses utility of tumor cfDNA as predictor of therapeutic response to immunotherapy

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Fish oil supplements combined with anti-cancer therapy can reduce renal cell carcinoma

Fish oil supplements combined with anti-cancer therapy can reduce renal cell carcinoma